Clinical Trial: Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

U.S., Jan. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06791941) titled 'Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer' on Jan. 16.

Brief Summary: Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue samples is planned for the study of the mutational profile, the transcriptional profile and the proteomic profile.

Study Start Date: March 07, 2024

Study Type: OBSERVATIONAL

Condition: Head and Neck Tumors

Intervention: BIOLOGICAL: Culture of organoids

Culture of organoids prepared from both the primary tumor and the...